Transformation of Myelodysplastic Syndrome to Acute Lymphoblastic Leukemia

A Case Report and Review of the Literature

Norihide Sato, Tomonori Nakazato, Masahiro Kizaki, Yasuo Ikeda, Shinichiro Okamoto

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Myelodysplastic syndrome (MDS) often transforms into acute leukemia, usually of a myeloid phenotype. However, the transformation of MDS into acute lymphoblastic leukemia (ALL) is extremely rare. We present a case of refractory anemia with excess of blasts (RAEB) that transformed into ALL. MDS (RAEB) was diagnosed in a 68-year-old Japanese woman in August 2001. Two months later, MDS progressed to erythroleukemia (French-American-British [FAB]classification, acute myeloid leukemia [AML]-M6), and in December, 2001, she was treated with combined chemotherapy containing aclarubicin, cytarabine, and granulocyte colony-stimulating factor, which improved her clinical symptoms. However, 1 month after the chemotherapy, she developed ALL. The blasts at that time had a markedly basophilic cytoplasm with multiple cytoplasmic vacuoles, and their morphology mimicked that of ALL-L3. The blasts also expressed CD13, a myeloid marker, in addition to lymphoid markers. Southern-blot analysis revealed rearrangement of the immunoglobulin heavy chain, but no additional chromosomal abnormality characteristic of ALL-L3 was detected. The patient was treated with chemotherapy, but she developed tumor lysis syndrome and died of multiple organ failure. Although the precise mechanism of lymphoid transformation is not yet fully understood, this case clinically supports the nature of MDS as a pluripotent hematopoietic stem cell disorder.

Original languageEnglish
Pages (from-to)147-151
Number of pages5
JournalInternational Journal of Hematology
Volume79
Issue number2
Publication statusPublished - 2004 Feb

Fingerprint

Myelodysplastic Syndromes
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Refractory Anemia with Excess of Blasts
Leukemia, Erythroblastic, Acute
Drug Therapy
Aclarubicin
Tumor Lysis Syndrome
Immunoglobulin Heavy Chains
Pluripotent Stem Cells
Multiple Organ Failure
Cytarabine
Granulocyte Colony-Stimulating Factor
Hematopoietic Stem Cells
Southern Blotting
Vacuoles
Chromosome Aberrations
Cytoplasm
Leukemia
Phenotype

Keywords

  • Acute lymphoblastic leukemia (ALL)
  • Myelodysplastic syndrome

ASJC Scopus subject areas

  • Hematology

Cite this

Transformation of Myelodysplastic Syndrome to Acute Lymphoblastic Leukemia : A Case Report and Review of the Literature. / Sato, Norihide; Nakazato, Tomonori; Kizaki, Masahiro; Ikeda, Yasuo; Okamoto, Shinichiro.

In: International Journal of Hematology, Vol. 79, No. 2, 02.2004, p. 147-151.

Research output: Contribution to journalArticle

@article{3dad0051db664555b3fb5f0b99f8fdd3,
title = "Transformation of Myelodysplastic Syndrome to Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature",
abstract = "Myelodysplastic syndrome (MDS) often transforms into acute leukemia, usually of a myeloid phenotype. However, the transformation of MDS into acute lymphoblastic leukemia (ALL) is extremely rare. We present a case of refractory anemia with excess of blasts (RAEB) that transformed into ALL. MDS (RAEB) was diagnosed in a 68-year-old Japanese woman in August 2001. Two months later, MDS progressed to erythroleukemia (French-American-British [FAB]classification, acute myeloid leukemia [AML]-M6), and in December, 2001, she was treated with combined chemotherapy containing aclarubicin, cytarabine, and granulocyte colony-stimulating factor, which improved her clinical symptoms. However, 1 month after the chemotherapy, she developed ALL. The blasts at that time had a markedly basophilic cytoplasm with multiple cytoplasmic vacuoles, and their morphology mimicked that of ALL-L3. The blasts also expressed CD13, a myeloid marker, in addition to lymphoid markers. Southern-blot analysis revealed rearrangement of the immunoglobulin heavy chain, but no additional chromosomal abnormality characteristic of ALL-L3 was detected. The patient was treated with chemotherapy, but she developed tumor lysis syndrome and died of multiple organ failure. Although the precise mechanism of lymphoid transformation is not yet fully understood, this case clinically supports the nature of MDS as a pluripotent hematopoietic stem cell disorder.",
keywords = "Acute lymphoblastic leukemia (ALL), Myelodysplastic syndrome",
author = "Norihide Sato and Tomonori Nakazato and Masahiro Kizaki and Yasuo Ikeda and Shinichiro Okamoto",
year = "2004",
month = "2",
language = "English",
volume = "79",
pages = "147--151",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Transformation of Myelodysplastic Syndrome to Acute Lymphoblastic Leukemia

T2 - A Case Report and Review of the Literature

AU - Sato, Norihide

AU - Nakazato, Tomonori

AU - Kizaki, Masahiro

AU - Ikeda, Yasuo

AU - Okamoto, Shinichiro

PY - 2004/2

Y1 - 2004/2

N2 - Myelodysplastic syndrome (MDS) often transforms into acute leukemia, usually of a myeloid phenotype. However, the transformation of MDS into acute lymphoblastic leukemia (ALL) is extremely rare. We present a case of refractory anemia with excess of blasts (RAEB) that transformed into ALL. MDS (RAEB) was diagnosed in a 68-year-old Japanese woman in August 2001. Two months later, MDS progressed to erythroleukemia (French-American-British [FAB]classification, acute myeloid leukemia [AML]-M6), and in December, 2001, she was treated with combined chemotherapy containing aclarubicin, cytarabine, and granulocyte colony-stimulating factor, which improved her clinical symptoms. However, 1 month after the chemotherapy, she developed ALL. The blasts at that time had a markedly basophilic cytoplasm with multiple cytoplasmic vacuoles, and their morphology mimicked that of ALL-L3. The blasts also expressed CD13, a myeloid marker, in addition to lymphoid markers. Southern-blot analysis revealed rearrangement of the immunoglobulin heavy chain, but no additional chromosomal abnormality characteristic of ALL-L3 was detected. The patient was treated with chemotherapy, but she developed tumor lysis syndrome and died of multiple organ failure. Although the precise mechanism of lymphoid transformation is not yet fully understood, this case clinically supports the nature of MDS as a pluripotent hematopoietic stem cell disorder.

AB - Myelodysplastic syndrome (MDS) often transforms into acute leukemia, usually of a myeloid phenotype. However, the transformation of MDS into acute lymphoblastic leukemia (ALL) is extremely rare. We present a case of refractory anemia with excess of blasts (RAEB) that transformed into ALL. MDS (RAEB) was diagnosed in a 68-year-old Japanese woman in August 2001. Two months later, MDS progressed to erythroleukemia (French-American-British [FAB]classification, acute myeloid leukemia [AML]-M6), and in December, 2001, she was treated with combined chemotherapy containing aclarubicin, cytarabine, and granulocyte colony-stimulating factor, which improved her clinical symptoms. However, 1 month after the chemotherapy, she developed ALL. The blasts at that time had a markedly basophilic cytoplasm with multiple cytoplasmic vacuoles, and their morphology mimicked that of ALL-L3. The blasts also expressed CD13, a myeloid marker, in addition to lymphoid markers. Southern-blot analysis revealed rearrangement of the immunoglobulin heavy chain, but no additional chromosomal abnormality characteristic of ALL-L3 was detected. The patient was treated with chemotherapy, but she developed tumor lysis syndrome and died of multiple organ failure. Although the precise mechanism of lymphoid transformation is not yet fully understood, this case clinically supports the nature of MDS as a pluripotent hematopoietic stem cell disorder.

KW - Acute lymphoblastic leukemia (ALL)

KW - Myelodysplastic syndrome

UR - http://www.scopus.com/inward/record.url?scp=1442334987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442334987&partnerID=8YFLogxK

M3 - Article

VL - 79

SP - 147

EP - 151

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 2

ER -